Ability of SARC-F to Find Probable Sarcopenia Cases in Older Adults

被引:24
|
作者
Sacar, D. Erbas [1 ]
Kilic, C. [1 ]
Karan, M. A. [1 ]
Bahat, Gulistan [1 ]
机构
[1] Istanbul Univ, Istanbul Med Sch, Dept Internal Med, Div Geriatr, TR-34390 Istanbul, Turkey
关键词
Sarcopenia; probable sarcopenia; screening; diagnosis; geriatric practice; MINI-NUTRITIONAL ASSESSMENT; DISABILITY;
D O I
10.1007/s12603-021-1617-3
中图分类号
R592 [老年病学]; C [社会科学总论];
学科分类号
03 ; 0303 ; 100203 ;
摘要
Background/Objective In 2018 EWGSOP2 has suggested low muscle strength as the primary parameter of sarcopenia. The consensus has recommended SARC-F questionnaire as a screening test to find cases with low muscle strength which has been designated as probable sarcopenia. We aimed to study the ability of SARC-F to find probable sarcopenia cases in older patients. Design Retrospective, cross-sectional. Setting Istanbul University Istanbul Faculty of Medicine Participants A total of 456 older adults (71.1% female, mean age: 74.6 +/- 6.6 years) Measurements We diagnosed probable sarcopenia by EWGSOP 2 criteria, i.e., presence of low handgrip strength (HGS). SARC-F questionnaire was performed by all participants. We used a receiver operating characteristics curve to obtain SARC-F cut-off values to detect probable sarcopenia and calculated the area under the curve and 95% confidence interval (CI). Results We included 456 participants (71.1% female; mean age: 74.6 +/- 6.6 years). Probable sarcopenia was present in 58 (12.7%). SARC-F cut-off >= 2 presented the best balance between sensitivity and specificity (sensitivity: 64.9% vs specificity: 67.9%) to detect probable sarcopenia [the area under the receiver operating characteristics curve (AUC) = 0.710; 95% Cl: 0.660-0.752, p< 0.001]. SARC-F with a cutoff point >= 1 had sensitivity 84.2% and specificity 40.5% and SARC-F >= 4 had high specificity 88.2% with 40.3% sensitivity. Conclusion SARC-F is a good screening tool for sarcopenia in practice. Our findings suggest SARC-F >= 1 cut-off point to be used as the probable sarcopenia screening tool regarding its high sensitivity. Consequently, SARC-F >= 4 cut-off is better to be used if one prefers to exclude probable sarcopenia.
引用
收藏
页码:757 / 761
页数:5
相关论文
共 50 条
  • [21] Limitations of SARC-F as a Screening Tool for Sarcopenia in Patients on Hemodialysis
    Imamura, Keigo
    Yamamoto, Shohei
    Suzuki, Yuta
    Matsuzawa, Ryota
    Harada, Manae
    Yoshikoshi, Shun
    Yoshida, Atsushi
    Matsunaga, Atsuhiko
    NEPHRON, 2022, 146 (01) : 32 - 39
  • [22] Comparing SARC-CalF With SARC-F for Screening Sarcopenia in Adults With Type 2 Diabetes Mellitus
    Xu, Zeru
    Zhang, Ping
    Chen, Yifei
    Jiang, Jiahong
    Zhou, Zijun
    Zhu, Hong
    FRONTIERS IN NUTRITION, 2022, 9
  • [23] Screening for sarcopenia with SARC-F in older patients hospitalized with cardiovascular disease
    Noda, Takumi
    Kamiya, Kentaro
    Hamazaki, Nobuaki
    Yamashita, Masashi
    Miki, Takashi
    Nozaki, Kohei
    Uchida, Shota
    Ueno, Kensuke
    Maekawa, Emi
    Terada, Tasuku
    Reed, Jennifer L.
    Yamaoka-Tojo, Minako
    Matsunaga, Atsuhiko
    Ako, Junya
    EUROPEAN JOURNAL OF CARDIOVASCULAR NURSING, 2024, 23 (06) : 675 - 684
  • [24] Translation and Validation of the Spanish Version of the SARC-F Questionnaire to Assess Sarcopenia in Older People
    Dolores Sánchez-Rodríguez
    E. Marco
    V. Dávalos-Yerovi
    J. López-Escobar
    M. Messaggi-Sartor
    C. Barrera
    N. Ronquillo-Moreno
    O. Vázquez-Ibar
    A. Calle
    M. Inzitari
    K. Piotrowicz
    X. Duran
    F. Escalada
    J. M. Muniesa
    E. Duarte
    The journal of nutrition, health & aging, 2019, 23 : 518 - 524
  • [25] Translation and Validation of the Spanish Version of the SARC-F Questionnaire to Assess Sarcopenia in Older People
    Sanchez-Rodriguez, D.
    Marco, E.
    Davalos-Yerovi, V.
    Lopez-Escobar, J.
    Messaggi-Sartor, M.
    Barrera, C.
    Ronquillo-Moreno, N.
    Vazquez-Ibar, O.
    Calle, A.
    Inzitari, M.
    Piotrowicz, K.
    Duran, X.
    Escalada, F.
    Muniesa, J. M.
    Duarte, E.
    JOURNAL OF NUTRITION HEALTH & AGING, 2019, 23 (06) : 518 - 524
  • [26] SARC-F for Screening of Sarcopenia Among Older Adults: A Meta-analysis of Screening Test Accuracy
    Ida, Satoshi
    Kaneko, Ryutaro
    Murata, Kazuya
    JOURNAL OF THE AMERICAN MEDICAL DIRECTORS ASSOCIATION, 2018, 19 (08) : 685 - 689
  • [27] Validating the SARC-F: A Suitable Community Screening Tool for Sarcopenia?
    Woo, Jean
    Leung, Jason
    Morley, John E.
    JOURNAL OF THE AMERICAN MEDICAL DIRECTORS ASSOCIATION, 2014, 15 (09) : 630 - 634
  • [28] Polish Translation and Validation of the SARC-F Tool for the Assessment of Sarcopenia
    Zasadzka, Ewa
    Pieczynska, Anna
    Trzmiel, Tomasz
    Pawlaczyk, Mariola
    CLINICAL INTERVENTIONS IN AGING, 2020, 15 : 567 - 574
  • [29] Comparing SARC-F with SARC-CalF for screening sarcopenia in advanced cancer patients
    Fu, Xiaofen
    Tian, Zhen
    Thapa, Sudip
    Sun, Huihui
    Wen, Su
    Xiong, Huihua
    Yu, Shiying
    CLINICAL NUTRITION, 2020, 39 (11) : 3337 - 3345
  • [30] French translation and validation of the sarcopenia screening tool SARC-F
    Charlotte Beaudart
    Médéa Locquet
    Stephen Bornheim
    Jean-Yves Reginster
    Olivier Bruyère
    European Geriatric Medicine, 2018, 9 : 29 - 37